2016
DOI: 10.1016/j.ijpharm.2015.11.034
|View full text |Cite
|
Sign up to set email alerts
|

Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 81 publications
0
19
0
Order By: Relevance
“…Some cationic LAAs also show interesting biologic properties, such as in vitro antimicrobial and antibiofilm activities and promising anticancer activity (IC50 15.3-22.4 μmol L −1 ) in several human cancer cell lines [21][22][23]. 14 14 C 3 (C 16 His) 2 LAAs have also been studied as drug delivery agents for hydrophobic anticancer [24,25] and antimicrobial [26][27][28] drugs to enhance drug solubilization and bioavailability. LAAs improved the solubility of an investigational anticancer drug from <0.15 µg mL −1 to 8.62 mg mL −1 , being more efficient than nonionic polymeric surfactant polysorbate 80 being used as a model solubilizer, which only achieved 3.16 mg mL −1 drug solubilization [24].…”
Section: Structure and Characterizationmentioning
confidence: 99%
See 2 more Smart Citations
“…Some cationic LAAs also show interesting biologic properties, such as in vitro antimicrobial and antibiofilm activities and promising anticancer activity (IC50 15.3-22.4 μmol L −1 ) in several human cancer cell lines [21][22][23]. 14 14 C 3 (C 16 His) 2 LAAs have also been studied as drug delivery agents for hydrophobic anticancer [24,25] and antimicrobial [26][27][28] drugs to enhance drug solubilization and bioavailability. LAAs improved the solubility of an investigational anticancer drug from <0.15 µg mL −1 to 8.62 mg mL −1 , being more efficient than nonionic polymeric surfactant polysorbate 80 being used as a model solubilizer, which only achieved 3.16 mg mL −1 drug solubilization [24].…”
Section: Structure and Characterizationmentioning
confidence: 99%
“…The micelles that were formed by a gemini LAA derived from cysteine, (C 8 Cys) 2 , under biomimetic conditions (phosphate buffered-saline (PBS), pH 7.4) were able to solubilize antifungal agent amphotericin B in its monomeric and less toxic form, which increased the molar solubilization ratio of the hydrophobic drug to 0.072 as compared to 0.036 in the commercial deoxycholate micellar formulation [26,27]. Cationic vesicles that formed by the lysine gemini LAA, C 6 (LL) 2 ( Figure 1) and cholesterol showed sustained and controlled release of methotrexate in vitro.…”
Section: -7n(gly)-12mentioning
confidence: 99%
See 1 more Smart Citation
“…The polar headgroup of LAA, which contains both donor and acceptor hydrogen bonding groups capable of intra‐ and intermolecular interactions, adds further complexity to their self‐assembly behavior. LAA have been employed as drug delivery agents for hydrophobic drugs (Ménard et al, ; Serafim et al, ), enhancing drug solubilization and bioavailability. Moreover, LAA are obtained from naturally renewable sources and can be produced by green‐chemistry approaches that include biotechnological procedures, such as fermentation or enzymatic catalysis (Ménard et al, ; Pérez et al, ; Pinazo et al, ; Serafim et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…19 Studies have reported that the combined use of bile salts with compounds, such as phospholipids, fatty acids, and polyamines, may improve their effectiveness as absorption enhancers and allow a decrease in their concentrations, thus reducing the risks of membrane dissolution. 20,21 Researchers have reported that the conjugation of cholic acid to anticancer drugs, such as carboplatin and cisplatin, resulted in significant antitumor efficiency in platinum-resistant tumor models. 18,22 The organotropism of bile acids can also help overcome chemotherapy resistance of enterohepatic tumors and reduce noxious side effects to healthy tissue by selectively targeting drugs to tumor cells.…”
Section: Introductionmentioning
confidence: 99%